Resultado de búsqueda
Hace 4 días · Franz J Legat received honoraria as a consultant and/or advisory board member and/or speaker for Almirall, Celgene, Eli Lilly, Galderma, Menlo Therapeutics, Novartis, Pelpharma, Pfizer, Sanofi, Trevi Therapeutics, Vifor Pharma; received support for participating in scientific meetings from Amgen, AbbVie, Celgene, Eli Lilly, Galderma, Janssen-Cilag, Leo Pharma, Novartis, Pelpharma, Pfizer ...
Hace 2 días · Introduction The introduction of biological therapies has revolutionized the treatment of moderate-to-severe plaque psoriasis. In particular, ixekizumab, an inhibitor of interleukin-17A, has shown great results in terms of efficacy and safety in both clinical trials and real-world experiences. However, there is a lack of long-term real-world data available for ixekizumab. Methods We conducted ...
Hace 3 días · This continuing education activity will highlight the importance of targeting pathways of disease progression in early MS, including the developing role of Bruton’s tyrosine kinase (BTK) inhibitors. This class of agents disarms both the peripheral (i.e., lymphocyte) and central, chronically activated (i.e., microglia/macrophage) cells that ...
Hace 3 días · La poltrona Barcelona (Barcelona chair) è stata disegnata da Ludwig Mies van der Rohe e Lilly Reich (sua compagna e unica donna invitata ad insegnare alla scuola del Bauhaus) per il padiglione tedesco dell'Esposizione Universale di Barcellona del 1929, anch'esso progettato da Mies van der Rohe.
Hace 1 día · MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa VELA is the first Phase 3 program in hidradenitis ...
Hace 4 días · #1694 Regine Leibinger on the 2024 Billionaires - Regine Leibinger owns 29.4% of the world's largest manufacturer of machine tools, TRUMPF. The company
Hace 1 día · 16 days ago - Forbes. Get a real-time Eli Lilly and Company (LLY) stock price quote with breaking news, financials, statistics, charts and more.
